Pharmaceuticals

Rising Cancer Prevalence And Its Impact On The Growth Of The Tecentriq (Atezolizumab) Is Contributing To Changes In The Fentanyl Market

April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Fentanyl Market From 2026 To 2030?

The fentanyl market has experienced notable growth in recent years. The market’s valuation is projected to rise from $17.15 billion in 2025 to $18.17 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.9%. Historically, this expansion has been driven by factors such as the increasing prevalence of chronic and cancer pain, a rise in postoperative surgeries, an expanding geriatric population, the widespread adoption of injectable opioids, and the development of hospital and clinical infrastructure.

The fentanyl market size is projected to experience substantial expansion over the coming years. It is forecast to reach $23.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is primarily driven by the advancement of novel fentanyl formulations, the incorporation of AI into pain management, increasing demand for home-based palliative care, a heightened emphasis on opioid safety and regulation, and the proliferation of ambulatory surgical centers. Key trends anticipated in this period encompass personalized pain management, innovative transdermal drug delivery systems, minimally invasive anesthesia techniques, opioid stewardship programs, and sophisticated formulation development.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

Which Key Drivers Are Affecting The Fentanyl Market Development?

The rising occurrence of chronic diseases is projected to drive the future growth of the fentanyl market. A chronic disease is identified as a medical condition that persists for an extended period, generally three months or longer, and often for a person’s entire life. Fentanyl’s primary application in chronic diseases is to manage severe, persistent pain that other medications or interventions have not effectively controlled. For example, in October 2025, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that in 2023, an estimated 57,100 adults aged 25 and above experienced acute coronary events, which averaged roughly 156 incidents each day. Therefore, the increasing prevalence of chronic diseases is significantly boosting the fentanyl market’s expansion.

Which Segment Categories Are Included In The Fentanyl Market Segment Analysis?

The fentanyl market covered in this report is segmented –

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations

2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems

What Trends Are Transforming The Fentanyl Market?

Leading companies in the fentanyl market are innovating products such as Opvee and obtaining approvals to cater to wider customer bases, generate higher sales, and increase revenue. Opvee, which contains nalmefene, is a potent blocker of opioid receptors designed for treating known or suspected opioid overdoses caused by natural or synthetic opioids, including fentanyl. For example, in May 2023, Indivior PLC, a U.S.-based pharmaceutical company, secured U.S. Food and Drug Administration approval for its Opvee nasal spray. This product operates by preventing opioids from affecting the brain, thereby assisting patients who have recently overdosed in restoring normal respiration and blood pressure. Opvee is administered as a nasal spray, facilitating its easy use during emergencies. It is a vital component among the various medications employed to combat opioid overdoses and save lives.

Who Are The Active Companies Shaping The Fentanyl Market?

Major companies operating in the fentanyl market are Pfizer Inc., Johnson & Johnson, Fresenius Kabi Oncology Ltd., Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Hisamitsu Pharmaceutical Co. Inc., Alvogen, Insys Therapeutics Inc., Paladin Labs Inc., Apotex Inc., Kyowa Kirin Co. Ltd., Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Sinopharm Group, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, Validus Pharmaceuticals LLC, Quality Care Products LLC, Bryant Ranch Prepack Inc., Exela Pharma Sciences LLC

Get The Full Fentanyl Market Report:

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Which Region Dominates The Fentanyl Market By Market Share?

North America was the largest region in the fentanyl market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Fentanyl Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Browse Through More Reports Similar to the Global Fentanyl Market 2026, By The Business Research Company

Fentanyl Market Report 2026

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Narcotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795